Vaping was supposed to get people off smoking. Now e-cig users are switching to cigarettes to try to quit

Surveys in New Zealand and the UK found that 14% and 19%, respectively, of respondents had used or tried using combustible cigarettes to quit vaping, highlighting a public-health messaging concern. U.S. adult smoking remains far below historical levels at 9.1% in 2025 versus 42.4% in 1965, while youth tobacco use fell to 7.2% and e-cigarette use to 5.2%. Experts warn that growing misperceptions of vaping as equally or more harmful than smoking could discourage nicotine users from moving away from cigarettes, which cause about 480,000 U.S. deaths annually.

Analysis

The investable read-through is not a broad tobacco-demand inflection but a potential mix shift within nicotine users. If replicated in U.S. scanner data, combustible volume erosion could slow modestly for MO and BTI's Reynolds franchise, while the more important negative would be to the growth narrative and valuation support for reduced-risk nicotine platforms, including MO's NJOY investment. The claimed behavior is based on small, non-U.S. surveys rather than observed purchases, so it is insufficient to alter volume models today.

The larger 6-18 month implication is regulatory: public-health messaging that acknowledges relative-risk differences could improve the FDA pathway for authorized vaping products while increasing enforcement pressure on illicit disposable vapes. That outcome would favor scaled, compliant operators such as MO and BTI over gray-market sellers, even if total nicotine consumption continues declining. Conversely, a renewed youth-use or lung-injury headline would likely preserve restrictive enforcement and impair reduced-risk multiple expansion.

RDDT has no material fundamental exposure; social discussion of smoking is not a monetizable demand signal absent evidence of sustained engagement, advertiser-category spending, or a change in platform policy. Consensus may overreact to cultural anecdotes, while missing the more relevant data point: whether U.S. adult cigarette volumes stabilize as vape use falls. Weekly Nielsen/IRI combustible volumes, FDA enforcement actions, and MO's NJOY shipment trends are the decision variables over the next 1-3 months.

Key Decisions for Investors

• No directional RDDT trade: maintain neutral exposure unless tobacco-related discussion produces a measurable, sustained lift in daily active users, engagement, or advertiser demand; this article alone has no earnings relevance.
• Place a 1-3 month watch on long MO / short PM: initiate only if U.S. cigarette-volume trends outperform PM's international heated-tobacco growth expectations and MO shows sequential NJOY shipment stabilization. The pair isolates a domestic combustible-resilience thesis from broad tobacco-sector beta.
• Treat MO reduced-risk exposure as the key falsifier: avoid adding to MO if disclosed NJOY volumes or retail distribution deteriorate materially for two consecutive reporting periods, since a cigarette-volume benefit would not offset renewed impairment risk in its non-combustible strategy.
• Monitor FDA marketing-order decisions and enforcement against unauthorized disposable vapes over the next 6-12 months. A clearer authorization path is incrementally positive for MO and BTI; another broad anti-vaping campaign or youth-use reversal would favor neither and argues for reducing any reduced-risk valuation premium.